Xponance, Inc. Organon & Co. Transaction History

Xponance, Inc.

$10.1 Billion
Q1 2025

A detailed history of Xponance, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Xponance, Inc. holds 13,828 shares of OGN stock, worth $127,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,828

Previous 12,005 15.19%

Holding current value

$127,494

Previous $179,000 14.53%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$14.29 - $16.41 $26,050 - $29,915	1,823 Added 15.19%	13,828 $205,000
Q4 2024 Feb 10, 2025	BUY	$14.44 - $18.83 $173,352 - $226,054	12,005 New	12,005 $179,000
Q1 2024 May 13, 2024	BUY	$13.78 - $18.8 $39,231 - $53,523	2,847 Added 26.27%	13,683 $257,000
Q4 2023 Jan 31, 2024	SELL	$10.95 - $17.32 $347,104 - $549,026	-31,699 Reduced 74.52%	10,836 $156,000
Q3 2023 Oct 23, 2023	BUY	$16.59 - $23.77 $29,828 - $42,738	1,798 Added 4.41%	42,535 $738,000
Q2 2023 Jul 13, 2023	BUY	$19.27 - $24.63 $32,161 - $41,107	1,669 Added 4.27%	40,737 $847,000
Q1 2023 Apr 17, 2023	BUY	$21.42 - $32.08 $51,043 - $76,446	2,383 Added 6.5%	39,068 $918,000
Q4 2022 Jan 23, 2023	BUY	$23.31 - $28.61 $147,832 - $181,444	6,342 Added 20.9%	36,685 $0
Q3 2022 Oct 24, 2022	BUY	$23.4 - $34.25 $127,249 - $186,251	5,438 Added 21.83%	30,343 $710,000
Q2 2022 Aug 02, 2022	BUY	$31.66 - $38.9 $284,623 - $349,711	8,990 Added 56.49%	24,905 $841,000
Q1 2022 Apr 20, 2022	BUY	$30.45 - $39.36 $15,194 - $19,640	499 Added 3.24%	15,915 $556,000
Q4 2021 Jan 31, 2022	BUY	$28.67 - $37.13 $78,240 - $101,327	2,729 Added 21.51%	15,416 $469,000
Q3 2021 Nov 05, 2021	SELL	$28.63 - $35.64 $46,180 - $57,487	-1,613 Reduced 11.28%	12,687 $416,000
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $406,835 - $543,400	14,300 New	14,300 $433,000

Others Institutions Holding OGN

# of Institutions

809

Shares Held

198M

Call Options Held

1.84M

Put Options Held

1.41M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $2.34B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account